Children born to women who take fish oil supplements during late pregnancy have better eye/hand coordination at age 2 to 3 years than their counterparts whose mothers did not take the supplements, according to a study published online Dec. 21 in the Archives of Disease in Childhood-Fetal and Neonatal Edition.
Children born to women who take fish oil supplements during late pregnancy have better eye/hand coordination at age 2 to 3 years than their counterparts whose mothers did not take the supplements, according to a study published online Dec. 21 in the Archives of Disease in Childhood-Fetal and Neonatal Edition.
Janet A. Dunstan, MD, of the University of Western Australia in Perth, and colleagues randomized
98 pregnant women to take about 4 g of n-3 long-chain polyunsaturated fatty acid (about the amount in
one fatty fish meal per day) or 4 g of olive oil per day from 20 weeks' gestation until birth. Researchers used standard measures to assess infant growth and cognitive development when the children turned age 2.5 years.
Children whose mothers took fish oil supplements scored significantly higher for eye/hand coordination than children whose mothers took olive oil supplements (mean score of 114 vs. 108, respectively). There were no significant differences in tests of receptive language, average phrase length and vocabulary. The fish oil supplements seemed safe in light of concerns about mercury toxicity.
Dunstan JA, Simmer K, Dixon G, et al. Cognitive assessment at 2½ years following fish oil supplementation in pregnancy: a randomized controlled trial. Arch Dis Child Fetal Neonatal Ed. Published Online First: 21 December 2006. doi:10.1136/adc.2006.099085.
FDA grants FTD to nipocalimab for treating FNAIT
March 26th 2024The FDA's Fast Track Designation for nipocalimab marks a significant step in addressing fetal neonatal alloimmune thrombocytopenia risk in pregnant patients, potentially revolutionizing treatment for this severe condition with unmet medical needs.
Read More
Study links low neighborhood food access to adverse birth outcomes
March 26th 2024A recent study highlighted the link between residence in low-income areas with limited food access during pregnancy and increased risks of lower birth weight and small for gestational age infants, urging further investigation into potential interventions for improved birth outcomes.
Read More
The impact of BMI on maternal feeding choices
March 22nd 2024Overweight or obese mothers face challenges in breastfeeding and breastfeeding duration, according to new research presented in a poster session at the NAPNAP 2024 National Conference on Pediatric Health Care in Denver, Colorado.
Read More
Study finds no link between prenatal antiseizure medication exposure and child epilepsy risk
March 8th 2024Recent research suggested that despite concerns about valproate use during pregnancy, prenatal exposure to antiseizure medications does not appear to raise the risk of epilepsy in offspring.
Read More
NIH study finds long-acting ART safe for HIV suppression in adolescents
March 7th 2024Research presented at the 2024 Conference on Retroviruses and Opportunistic Infections reveals that long-acting injectable antiretroviral therapy provides improved HIV suppression with minimal adverse effects, offering a promising alternative for adolescents and individuals struggling with daily oral regimens.
Read More